Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Redwood Pharma AB
  6. Summary
    REDW   SE0008294789

REDWOOD PHARMA AB

(REDW)
 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Stockholm
01/19/2022 01/20/2022 01/21/2022 01/24/2022 01/25/2022 Date
1.976(c) 1.982(c) 2(c) 1.85(c) 1.918(c) Last
42 949 41 565 40 335 69 459 34 376 Volume
-3.37% +0.30% +0.91% -7.50% +3.68% Change
More quotes
Estimated financial data (e)
Sales 2019 - - -
Net income 2019 -15,8 M -1,70 M -1,70 M
Net cash position 2019 8,16 M 0,88 M 0,88 M
P/E ratio 2019 -9,81x
Yield 2019 -
Sales 2020 - - -
Net income 2020 -14,5 M -1,57 M -1,57 M
Net cash position 2020 6,61 M 0,71 M 0,71 M
P/E ratio 2020 -7,36x
Yield 2020 -
Capitalization 39,8 M 4,28 M 4,30 M
EV / Sales 2019 -
EV / Sales 2020 -
Nbr of Employees 2
Free-Float 83,8%
More Financials
Company
Redwood Pharma AB is a Sweden-based company, which is primarily focused on pharmaceutical industry. The Company develops IntelliGel, a patented hydrogel drug delivery platform technology. IntelliGel is a patented supramolecular smart drug delivery system with an ability to dissolve water-insoluble and sparingly soluble drugs, or disperse, suspend and stabilize otherwise insoluble drugs. It is an odor-free, clear and... 
Sector
Pharmaceuticals
Calendar
02/16Earnings Release
More about the company
All news about REDWOOD PHARMA AB
01/24Redwood Pharma to attend the ARVO annual meeting and BIO-Europe (Fall) in 2022
AQ
2021REDWOOD PHARMA : RP501 represents an extension into the medical technology arena for Redwo..
PU
2021Redwood Pharma AB Reports Earnings Results for the Third Quarter and Nine Months Ended ..
CI
2021REDWOOD PHARMA AB : (publ) Quarterly Report January - June 2021
AQ
2021Redwood Pharma AB Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
2021Redwood Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2021
CI
2021Redwood Pharma AB Announces That Phase II Results Published in Medical Journal and Redw..
CI
2021Redwood Pharma AB Reports Earnings Results for the Fourth Quarter and Year Ended Decemb..
CI
2020Redwood Pharma AB Announces Supplementary Analyses to Topline Phase Ii Results Reveal A..
CI
2020Redwood Pharma AB Officially Names the New Development Project for Treatment of Mild Dr..
CI
2020Redwood Pharma Launches New Development Program for Mild Dry Eye Based on Its Proprieta..
CI
2020Redwood Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended ..
CI
2020Redwood Pharma Announces New Patent for the Use of Estrogens in the Treatment of DED to..
CI
2020Redwood Pharma Announces That Rp101 Demonstrated Efficacy and Safety in Phase II Study ..
CI
2020Redwood Pharma AB Reports Financial Results for the Fourth Quarter and Full Year Ended ..
CI
More news
News in other languages on REDWOOD PHARMA AB

- No features available -

More news
Chart REDWOOD PHARMA AB
Duration : Period :
Redwood Pharma AB Technical Analysis Chart | REDW | SE0008294789 | MarketScreener
Income Statement Evolution
Managers and Directors
Martin Vidaeus Chief Executive Officer & Director
Peter Rooslien Chief Financial Officer
Gunnar Mattsson Chairman
Ulf Bj÷rklund Chief Medical Officer
Hans Ageland Chief Operating Officer & Director
Sector and Competitors